Status:
NO_LONGER_AVAILABLE
A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous
Lead Sponsor:
Prometic Biotherapeutics, Inc.
Collaborating Sponsors:
Cedars-Sinai Medical Center
Vanderbilt University Medical Center
Conditions:
Hypoplasminogenemia
Eligibility:
All Genders
16+ years
Brief Summary
These are single-patient studies with repeat-dose administration of ProMetic Plasminogen IV infusion in one adult and one child with hypoplasminogenemia. These patients are under treatment to address ...
Eligibility Criteria
Inclusion
- Patient has provided informed consent.
- Patient has a diagnosis of compound homozygous Type 1 plasminogen deficiency as evidence by ligneous conjunctivitis since birth as well as involvement of the conjunctiva, nasopharynx, gingiva, tracheobronchial tree, gastrointestinal tract, and urinary tract.
Exclusion
- Not applicable
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03265171
Last Update
April 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.